NCT04745988 2026-04-09An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric CancerNational Cancer Center Hospital EastPhase 2 Active not recruiting43 enrolled